Concepedia

Ansgar Brüning

AB

Statistics

Publications

43

Citations

1.6K

H-Index

25

Active since

2001

Affiliations

Ludwig-Maximilians-Universität München(Current)

München Klinik Neuperlach

München Klinik

Heidelberg University

University of Freiburg

Ansgar Brüning is an author at Ludwig-Maximilians-Universität München specializing in molecular oncology, oncology, and medicine.

Publications per year

2001–2016

43

Publications

43

Nelfinavir and bortezomib inhibit mTOR activity via ATF4‐mediated sestrin‐2 regulation

Ansgar Brüning, Martina Rahmeh, Klaus Friese · Molecular Oncology · 2013 · 138 citations · Full text

, , +17

Correction: Evidence of inhibin/activin subunit betaC and betaE synthesis in normal human endometrial tissue

Ioannis Mylonas, Ansgar Brüning, Naim Shabani et al. · Reproductive Biology and Endocrinology · 2011 · 125 citations · Full text

, , +5

Proteasome inhibition by quercetin triggers macroautophagy and blocks mTOR activity

Anja Klappan, Stefanie Hones, Ioannis Mylonas et al. · Histochemistry and Cell Biology · 2011 · 90 citations

, , +12

The metastasis-associated gene MTA1 is upregulated in advanced ovarian cancer, represses ERβ, and enhances expression of oncogenic cytokine GRO

Christine Dannenmann, Naim Shabani, Klaus Friese et al. · Cancer Biology & Therapy · 2008 · 75 citations · Full text

, , +17

CAR is a cell–cell adhesion protein in human cancer cells and is expressionally modulated by dexamethasone, TNFα, and TGFβ

Ansgar Brüning, Ingo B. Runnebaum · Gene Therapy · 2003 · 70 citations

, , +14

1–5 of 43